BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10483096)

  • 1. Expression of aphidicolin, FUdR and caffeine-induced fragile sites in lymphocytes of healthy Turkish individuals.
    Güven GS; Hacihanefioğlu S; Cenani A
    Genetica; 1999; 105(1):109-16. PubMed ID: 10483096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragile sites induced by FUdR, caffeine, and aphidicolin. Their frequency, distribution, and analysis.
    Rao PN; Heerema NA; Palmer CG
    Hum Genet; 1988 Jan; 78(1):21-6. PubMed ID: 2962925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical induction of sister chromatid exchange at fragile sites.
    Wenger SL
    Cancer Genet Cytogenet; 1995 Nov; 85(1):72-4. PubMed ID: 8536242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population cytogenetics of aphidicolin-induced fragile sites.
    Tedeschi B; Vernole P; Sanna ML; Nicoletti B
    Hum Genet; 1992 Jul; 89(5):543-7. PubMed ID: 1634231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of caffeine on fragile X expression.
    Abruzzo MA; Pettay D; Mayer M; Jacobs PA
    Hum Genet; 1986 May; 73(1):20-2. PubMed ID: 2940164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast-specific common fragile sites induced by aphidicolin.
    Murano I; Kuwano A; Kajii T
    Hum Genet; 1989 Aug; 83(1):45-8. PubMed ID: 2504659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragile site expression in families with von Hippel-Lindau disease.
    Jordan DK; Divelbiss JE; Waziri MH; Burns TL; Patil SR
    Cancer Genet Cytogenet; 1989 Jun; 39(2):157-66. PubMed ID: 2526679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of fragile sites in lymphocytes of patients with rectum cancer and their first-degree relatives.
    Tunca B; Egeli U; Zorluoğlu A; Yilmazlar T; Yerci O; Kizil A
    Cancer Lett; 2000 May; 152(2):201-9. PubMed ID: 10773413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common fragile sites in chromosomes of bone marrow cells and peripheral blood lymphocytes from healthy persons and leukemia patients.
    Furuya T; Ochi H; Watanabe S
    Cancer Genet Cytogenet; 1989 Nov; 43(1):131-8. PubMed ID: 2790768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Induction of fragile sites by chemical and physical agents].
    Fundia AF; Larripa IB
    Acta Physiol Pharmacol Ther Latinoam; 1991; 41(3):359-67. PubMed ID: 1843869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression frequency of common fragile sites and genetic predisposition to colon cancer.
    Tunca B; Egeli U; Zorluoglu A; Yilmazlar T; Yerci O; Kizil A
    Cancer Genet Cytogenet; 2000 Jun; 119(2):139-45. PubMed ID: 10867150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coincidence in fragile site expression with fluorodeoxyuridine and bromodeoxyuridine.
    Fundia AF; Larripa IB
    Cancer Genet Cytogenet; 1989 Aug; 41(1):41-8. PubMed ID: 2527595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal fragile site expression in Turkish psychiatric patients.
    Taştemir D; Demirhan O; Sertdemir Y
    Psychiatry Res; 2006 Nov; 144(2-3):197-203. PubMed ID: 17007939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome breaks and fragile sites in leukemic bone marrow cells.
    Przylepa KA; Wenger SL
    Cancer Genet Cytogenet; 1988 Jul; 33(1):35-8. PubMed ID: 2968151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The most common fragile site in man is 3p14.
    Smeets DF; Scheres JM; Hustinx TW
    Hum Genet; 1986 Mar; 72(3):215-20. PubMed ID: 2937710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of genetic susceptibility to non-small cell lung cancer by fragile site expression.
    Tunca B; Cecener G; Gebitekin C; Egeli U; Ediz B; Ercan I
    Teratog Carcinog Mutagen; 2002; 22(3):205-15. PubMed ID: 11948631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New common fragile sites.
    Hecht F; Tajara EH; Lockwood D; Sandberg AA; Hecht BK
    Cancer Genet Cytogenet; 1988 Jul; 33(1):1-9. PubMed ID: 2454726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common fragile sites: their prevalence in subjects with constitutional and acquired chromosomal instability.
    Tedeschi B; Porfirio B; Vernole P; Caporossi D; Dallapiccola B; Nicoletti B
    Am J Med Genet; 1987 Jun; 27(2):471-82. PubMed ID: 3111262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonrandom distribution of methotrexate-induced aberrations on human chromosomes. Detection of further folic acid sensitive fragile sites.
    Barbi G; Steinbach P; Vogel W
    Hum Genet; 1984; 68(4):290-4. PubMed ID: 6239815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive fragile sites 1p31, 3p14, 6q26, and 16q23 and their use as controls for false-negative results with the fragile(X).
    Daniel A; Ekblom L; Phillips S
    Am J Med Genet; 1984 Jul; 18(3):483-91. PubMed ID: 6476008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.